Outcome
    Moderate Evidence

    Red Clover for Hot Flash Reduction

    Red clover isoflavones produce small-to-modest hot flash reductions, best in women with five or more daily flashes.

    Overview

    Red clover isoflavones produce small-to-modest hot flash reductions, best in women with five or more daily flashes.

    Verdict

    Mixed evidence

    How It Works

    Isoflavones (biochanin A, formononetin) bind estrogen receptor beta preferentially, mildly modulating thermoregulation.

    Dosing & Protocol

    Typical dose

    Recommended dose
    40–80 mg/day isoflavones standardized extract.
    Expected timeframe
    12 weeks

    Protocol

    form
    Standardised extract providing isoflavones - biochanin A, formononetin, genistein and daidzein. Promensil, standardised to 40 mg isoflavones per tablet, was used in most trials
    duration
    12 weeks minimum before judging - hot flush trials show high placebo response early
    co factor
    Take with food. Evidence is mixed. A Cochrane review of phytoestrogens for menopausal symptoms found red clover isoflavones produced no consistent reduction in hot flush frequency compared with placebo, though some individual trials and a later meta-analysis suggested modest reductions of roughly one to two flushes per day at 80 mg/day. Placebo response in hot flush trials is unusually high - often 30-50% - which makes small effects difficult to detect and easy to overstate. Mechanism is weak oestrogen receptor binding, with preference for ER-beta.
    titration
    Increase to 80 mg/day if no response after 8 weeks; most trials used 40-80 mg/day
    starting dose
    40 mg/day of standardised red clover isoflavones with food

    Evidence

    What the studies say

    Meta-analyses show a small but statistically significant reduction in flash frequency versus placebo, driven by studies of women with high baseline frequency. Effects are smaller than HRT and take 8–12 weeks.

    Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Score: 6/10
    2021
    meta_analysis
    0

    Kanadys W, Baranska A, Blaszczuk A +4 more

    Red clover isoflavones significantly reduced daily hot flush frequency versus placebo, with a modest effect size.

    View source

    Safety and Efficacy of Black Cohosh and Red Clover for the Management of Vasomotor Symptoms: A Randomized Controlled Trial

    Score: 8/10
    2009
    rct
    n=89

    Geller SE, Shulman LP, van Breemen RB +10 more

    Neither red clover nor black cohosh reduced vasomotor symptoms significantly more than placebo over 12 months.

    View source

    Phytoestrogens for menopausal vasomotor symptoms

    Score: 9/10
    2013
    systematic_review
    0

    Lethaby A, Marjoribanks J, Kronenberg F +3 more

    Pooled trials of red clover extracts showed no consistent reduction in hot flush frequency compared with placebo.

    View source

    Safety

    Caveats

    Estrogen-sensitive conditions: discuss with a clinician. May interact with tamoxifen. Allow a full 12-week trial.

    Less likely to help if

    Women with fewer than 3–4 flashes/day; equol non-producers may respond less.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.